Humacyte Inc
NASDAQ:HUMA

Watchlist Manager
Humacyte Inc Logo
Humacyte Inc
NASDAQ:HUMA
Watchlist
Price: 1.08 USD -4.42% Market Closed
Market Cap: 202.3m USD

Wall Street
Price Targets

HUMA Price Targets Summary
Humacyte Inc

Wall Street analysts forecast HUMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUMA is 8.01 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

Lowest
Price Target
3.03 USD
181% Upside
Average
Price Target
8.01 USD
642% Upside
Highest
Price Target
26.25 USD
2 331% Upside
Humacyte Inc Competitors:
Price Targets
LVTX
LAVA Therapeutics NV
20% Downside
RLYB
Rallybio Corp
39% Upside
NGNE
Neurogene Inc
200% Upside
ASMB
Assembly Biosciences Inc
43% Upside
ZNTL
Zentalis Pharmaceuticals Inc
293% Upside
SPRB
Spruce Biosciences Inc
154% Upside
RCUS
Arcus Biosciences Inc
42% Upside
302440
SK Bioscience Co Ltd
22% Downside

Revenue
Forecast

Revenue Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Humacyte Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HUMA's stock price target?
Price Target
8.01 USD

According to Wall Street analysts, the average 1-year price target for HUMA is 8.01 USD with a low forecast of 3.03 USD and a high forecast of 26.25 USD.

Back to Top